Devadatt M. Mishal serves as Executive at TransBiotec, Inc., where they oversee executive responsibilities. Since joining the company, Devadatt M. Mishal has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 28, 2019 involved purchasing 13,134,420 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 28, 2019 | IMLE | $0 | Purchase | 13,134,420 | $N/A | Discretionary |
Devadatt M. Mishal currently holds 20,534,857 shares of TransBiotec, Inc. (IMLE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Devadatt M. Mishal has been a net neutral trader of IMLE stock. They have purchased $0 and sold $0 worth of shares.
Devadatt M. Mishal's most recent insider trade was on Aug 28, 2019, when they purchased 13,134,420 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted